11.22.24 -- Pros And Cons Of Partnering With CDMOs Inside And Outside The US

Pharmaceutical and biotech companies must decide whether to outsource stability storage and testing or handle them in-house. Outsourcing offers cost savings, risk reduction, and compliance benefits. This webinar, featuring Darryl Souness and Stephen Delaney, will discuss risk mitigation, data quality, and cost management when outsourcing stability studies, along with best practices for protocol creation and risk assessment. Click here to learn more.

Conrad Wüllerm MSc, Director of Strategy and Operations, ARTBIO, Sesha Neervannan, Ph.D., COO, Tarsus Pharmaceuticals, and Bethany Dudek, CTO, Arcutis, discuss the benefits and challenges of partnering with CDMOs in the U.S. and globally, and offer advice on mitigating supply chain risks.

Review advanced retrosynthetic analysis services and how these tools empower better, more efficient development of innovative small molecule drugs.

Learn from experts and secure reliable testing solutions to eliminate the presence of nitrosamine drug substance-related impurities (NDSRIs) in medications.

Unlock the potential of nasal inhalation for delivering APIs by evaluating the advantages of both liquid and dry powder formulations as companies enhance local, systemic, and brain-targeted therapies.

Failure to identify a compound’s red flags early in development often manifests as program delays or failures. Discover how to avoid these setbacks through complete molecular characterization.

See how a top 20 U.S.-based pharma company achieved more capacity to meet commercial supply needs in an accelerated timeline followed by pre-approval inspection with the help of a CMO partner.

Accelerate your small molecule API program with a strategic CDMO partner with the experience, expertise, and flexibility required to solve the toughest small molecule challenges.

A partner with experts who are adept at working with complex, sensitive, and potent APIs; screening for the optimal formulation; and scaling up efficiently is vital for successful trials and commercialization.

Our expertise spans across a wide range of global markets. Our experience in securing regulatory approvals and navigating market challenges positions us as a trusted partner.

With high drug-loading capabilities and the option to combine with high-density formulations, MMTS™ is ideal for high-strength products. Experience the power of precision and flexibility with MMTS.